Synapse - Christopher Hulton

Christopher Hulton

Groups

Gerstner Sloan Kettering Graduate School of Biomedical Sciences
- Alumni (GSK)

Research Focus

Former Employee. GRADUATE SCHOOL ADMINISTRATION; GSK Graduate Student

21156

Recent additions – View all

STAT3-driven MAPK activation represents a therapeutic vulnerability in ASCL1 high SCLC
Meeting Abstract

Caeser, R.; Hulton, C.; Costa, E.; Durani, V.; Little, M.; Chen, X.; Tischfield, S. E.; Asher, M.; Kombak, F. E.; Chavan, S. S.; more...
Cancer Research (2022)

Fulltext@MSK | Save
MAPK pathway activation selectively inhibits ASCL1-driven small cell lung cancer
Journal Article

Caeser, R.; Hulton, C.; Costa, E.; Durani, V.; Little, M.; Chen, X.; Tischfield, S. E.; Asher, M.; Kombak, F. E.; Chavan, S. S.; more...
iScience (2021)

Fulltext@MSK | Save
MAPK pathway activation represents a therapeutic vulnerability in ASCL1-driven SCLC
Meeting Abstract

Caeser, R.; Hulton, C.; Durani, V.; Costa, E.; Little, M.; Shah, N. S.; de Stanchina, E.; Poirier, J. T.; Rudin, C. M.; Sen, T.
Cancer Research (2021)

Fulltext@MSK | Save

Co-authors at MSK

7

Rudin
6

De Stan...
5

Sen
5

Shah
3

Asher
3

Caeser
3

Costa
3

Durani
3

Little
2

Chavan
2

Chen
2

Ciampri...
2

Kombak
2

Quintan...
2

Richards
2

Tischfield
2

Uddin
1

Arbour
1

Bhanot
1

Buonocore
1

Donoghue
1

Hayatt
1

Heller
1

Martin
1

Poirier
1

Rekhtman
1

Shen
1

Wohlhieter

Types of Work

Publications